Company intelligence / Profile preview

Clinivex

South Plainfield, New Jersey, United States

Ownership: Private
Development stage: Other

Overview

Clinivex is a life science company that provides high-quality research reagents, biochemicals, and recombinant proteins to the global scientific community. The company offers a broad catalog of products including small molecule inhibitors, agonists, screening libraries, and specialized chemicals for oncology, immunology, and neuroscience research. Clinivex supports drug discovery and academic research by ensuring the availability of high-purity compounds and biological tools. Their services often include custom synthesis and bulk chemical sourcing to meet specific laboratory requirements.

Modalities: Small moleculeProteinPeptideAntibody
Industry: Drug Discovery Services

Beyond the preview

Go deeper on Clinivex.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Clinivex.

Explore the full profile